Exploiting novel valve interstitial cell lines to study calcific aortic valve disease.

Area of Science:

• Biomedical Engineering
• Cell Biology
• Cardiovascular Research

Background:

• Calcific aortic valve disease (CAVD) is characterized by valve leaflet thickening and calcification, leading to impaired motion.
• In vitro studies of CAVD commonly use primary cells, but immortalized cell lines have not been explored.

Purpose of the Study:

• To generate and evaluate immortalized sheep (SAVIC) and rat (RAVIC) valve interstitial cell (VIC) lines for their calcification potential.
• To establish a convenient and cost-effective in vitro model for investigating CAVD mechanisms.

Main Methods:

• Generated immortalized SAVIC and RAVIC lines using Simian virus 40 (SV40) T antigens.
• Induced calcification using calcium (Ca) and synergistic calcium/phosphate (Pi) conditions.
• Analyzed mRNA expression of key genes (RUNX2, PiT1, MGP) and assessed response to calcification inhibitors (pyrophosphate, etidronate).

Main Results:

• SAVIC and RAVIC lines exhibited significant calcification in response to Ca and Ca/Pi.
• Calcifying conditions altered mRNA expression of RUNX2, PiT1, and MGP in both cell lines.
• SAVIC calcification was reduced by pyrophosphate and etidronate treatment.

Conclusions:

• Immortalized SAVIC and RAVIC cell lines provide a reproducible and cost-effective in vitro system for CAVD research.
• These cell lines facilitate the investigation of CAVD pathophysiology and the evaluation of potential therapeutic interventions.